A Phase II Study of Weekly Docetaxel for Patients with Advanced or Recurrent Cancer of the Cervix

Publisher： Karger

E-ISSN： 1423-002x|64|4|193-198

ISSN： 0378-7346

Source： Gynecologic and Obstetric Investigation, Vol.64, Iss.4, 2007-07, pp. : 193-198

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Long-Term Survival of Patients with Apparent Early-Stage (FIGO I–II) Epithelial Ovarian Cancer: A Population-Based Study

By  

Gynecologic and Obstetric Investigation, Vol. 63, Iss. 3, 2006-01 ,pp. : 132-136

Karger

Access to resources Recommend Favorite

A Multicenter Study of the Importance of Systemic Chemotherapy for Patients with Small-Cell Neuroendocrine Carcinoma of the Uterine Cervix

By  

Gynecologic and Obstetric Investigation, Vol. 79, Iss. 3, 2014-12 ,pp. : 172-178

Karger

Access to resources Recommend Favorite

Pilot Phase 2 Trial of 4 Months of Maintenance Pegylated Liposomal Doxorubicin in Patients with Advanced Ovarian Cancer after Complete Response to Platinum and Paclitaxel-Based Chemotherapy

By  

Gynecologic and Obstetric Investigation, Vol. 63, Iss. 1, 2006-06 ,pp. : 1-6

Karger

Access to resources Recommend Favorite

Concurrent Weekly Nedaplatin, External Beam Radiotherapy and High-Dose-Rate Brachytherapy in Patients with FIGO Stage IIIb Cervical Cancer: A Comparison with a Cohort Treated by Radiotherapy Alone

By  

Gynecologic and Obstetric Investigation, Vol. 69, Iss. 4, 2010-01 ,pp. : 224-232

Karger

Access to resources Recommend Favorite

Different Patterns of Disease Spread between Advanced-Stage Type I and II Epithelial Ovarian Cancer

By  

Gynecologic and Obstetric Investigation, Vol. 81, Iss. 1, 2016-0 ,pp. : 10-14

Karger

Access to resources Recommend Favorite